Trevor Stone

Trevor Stone is an Honorary Senior Research Fellow at the University of Glasgow's School of Psychology & Neuroscience. His work focuses on neurodegenerative diseases, kynurenine pathway metabolism, and neuroprotection. He has contributed over 116 publications since 1992, exploring mechanisms linking tryptophan metabolism to diseases like Parkinson’s, Alzheimer’s, and cancer. His research highlights roles for serine proteases, oxidative stress, and neuroinflammation. Key findings include kynurenine pathway dysregulation in Huntington’s disease and stroke, and the neuroprotective potential of adenosine receptor modulation. He collaborates internationally on projects involving immunology, developmental neurobiology, and translational medicine. Professional networks include roles in drug discovery and clinical trials targeting neurodegenerative disorders.

Education & Affiliations: Training in neuroscience and pharmacology at the University of Glasgow, with extended collaborations at institutions like the University of Strathclyde and international partners in Argentina and Hungary. Active in editorial roles for journals including Neurochemistry International and European Journal of Neuroscience.

Research Themes: Extensive studies on kynurenine pathway enzymes (e.g., KMO, TDO), neuronal plasticity modulation by proteases, and gut-brain axis interactions. His work bridges basic science to clinical applications in neuroprotection and cancer biology.

Grants & Funding: Awards from UKRI, Wellcome Trust, and EU Horizon 2020 for projects on neurodegeneration and metabolic disease links. Current initiatives focus on novel therapeutic targets for Alzheimer’s and stroke recovery.